Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
Clinical trial NCT02332590 · COMPLETED
Trial details
- NCT number
- NCT02332590
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-28
- Primary completion
- 2016-01-20
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.